Oragenics Inc (OGEN)

Currency in USD
1.3198
+0.0098(+0.75%)
Real-time Data·
OGEN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
OGEN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.29031.3300
52 wk Range
1.230075.6000
Key Statistics
Prev. Close
1.31
Open
1.3
Day's Range
1.2903-1.33
52 wk Range
1.23-75.6
Volume
28.76K
Average Volume (3m)
638.97K
1-Year Change
-95.27%
Book Value / Share
0.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OGEN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.0000
Upside
+51.54%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Oragenics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Oragenics Inc Company Profile

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and lantibiotics. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Sarasota, Florida.

Compare OGEN to Peers and Sector

Metrics to compare
OGEN
Peers
Sector
Relationship
P/E Ratio
−0.1x−3.2x−0.5x
PEG Ratio
0.000.000.00
Price/Book
7.8x2.3x2.6x
Price / LTM Sales
-9.8x3.3x
Upside (Analyst Target)
52.7%202.7%43.5%
Fair Value Upside
Unlock8.7%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.0000
(+51.54% Upside)

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-3.65 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

OGEN Income Statement

People Also Watch

41.00
BMNR
+6.57%
0.546
WINT
-2.67%
17.66
SRPT
+8.61%
5.7320
BGLC
-1.00%
2.070
VOR
-0.97%

FAQ

What Stock Exchange Does Oragenics Trade On?

Oragenics is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Oragenics?

The stock symbol for Oragenics is "OGEN."

What Is the Oragenics Market Cap?

As of today, Oragenics market cap is 1.08M.

What Is Oragenics's Earnings Per Share (TTM)?

The Oragenics EPS (TTM) is -30.10.

From a Technical Analysis Perspective, Is OGEN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Oragenics Stock Split?

Oragenics has split 4 times.

How Many Employees Does Oragenics Have?

Oragenics has 4 employees.

What is the current trading status of Oragenics (OGEN)?

As of 07 Aug 2025, Oragenics (OGEN) is trading at a price of 1.32, with a previous close of 1.31. The stock has fluctuated within a day range of 1.29 to 1.33, while its 52-week range spans from 1.23 to 75.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.